Preferred Drug List Review Panel

Event Description

The Medicaid and Health Choice Preferred Drug List (PDL) Review Panel was established by DHHS to conduct open meetings to discuss recommended policies and procedures related to the PDL and to address the public comments that were received during the PDL comment period. The administration and review of the North Carolina Medicaid and Health Choice PDL follows the Preferred Drug List Review Panel Guidelines and Procedures.

To sign up to speak at the PDL Review Panel Meeting, send an email to  Please include the name of the speaker, the represented organization and the drug name.  You may attach any clinical information regarding the drug you wish the PDL Panel to review beforehand.  Presentations are allowed only in the drug classes with changes and should not exceed three minutes.

This event is related to: